Effects of carbon monoxide (CO) delivery by a CO donor or hemoglobin on vascular hypoxia inducible factor 1α and mitochondrial respiration

FEBS Open Bio

Volumn 2, Issue , 2012, Pages 113-118

  Reiter, Chad E N ^a   Alayash, Abdu I ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Carbon monoxide; Hemoglobin; Hypoxia inducible factor; Mitochondria

Indexed keywords

CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE 2; CARRIER PROTEIN; ENDOTHELIN 1; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; HYPOXIC CELL; LIGATION; MEMBRANE STABILIZATION; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN SENSING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BOVINAE;

EID: 84861923532     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2012.05.003     Document Type: Article

References (27)

1. Bauer I., Pannen B.H. Bench-to-Bedside review: carbon monoxide-from mitochondrial poisoning to therapeutic use. Crit. Care 2009, 13:220.
2. Wang R., Wu L. The chemical modification of KCa channels by carbon monoxide in vascular smooth muscle cells. J. Biol. Chem. 1997, 272:8222-8226.
3. Morita T., Mitsialis S.A., Koike H., et al. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J. Biol. Chem. 1997, 272:32804-32809.
4. Foresti R., Bani-Hani M.G., Motterlini R. Use of carbon monoxide as a therapeutic agent: promises and challenges. Intensive Care Med. 2008, 34:649-658.
5. Beckman J.D., Belcher J.D., Vineyard J.V., et al. Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1243-H1253.
6. Motterlini R., Mann B.E., Johnson T.R., et al. Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr. Pharm. Des. 2003, 9:2525-2539.
7. Vandegriff K.D., Young M.A., Lohman J., et al. CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats. Br. J. Pharmacol. 2008, 154:1649-1661.
8. Alayash A.I. Oxygen therapeutics: can we tame haemoglobin?. Nat. Rev. Drug Disc. 2004, 3:152-159.
9. Alayash A.I. Setbacks in blood substitutes research and development: a biochemical perspective. Clin. Lab. Med. 2010, 30:381-389.
10. Majmundar A.J., Wong W.J., Simon M.C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 2010, 40:294-309.
11. Yamashita K., Discher D.J., Hu J., et al. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/CBP. J. Biol. Chem. 2001, 276:12645-12653.
12. Silverman T.A., Weiskopf R.B. Hemoglobin-based oxygen carriers: current status and future directions. Anesthesiology 2009, 111:946-963.
13. Baek J.H., Reiter C.E.N., Manalo D.J., et al. Induction of hypoxia inducible factor (HIF-1α) in rat kidneys by iron chelation with the hydroxypyridinone, CP94. Biochim. Biophys. Acta 2011, 1809:262-268.
14. Klaus J.A., Kibler K.K., Abuchowski A., Koehler R.C. Early treatment of transient focal cerebral ischemia with bovine PEGylated carboxy hemoglobin transfusion. Artif. Cells Blood Substit. Immobil. Biotechnol. 2010, 38:223-229.
15. Dranka B.P., Hill B.G., Darley-Usmar V.M. Mitochondrial reserve capacity in endothelial cells: the impact of nitric oxide and reactive oxygen species. Free Radic. Biol. Med. 2010, 48:905-914.
16. Ferrick D.A., Neilson A., Beeson C. Advances in measuring cellular bioenergetics using extracellular flux. Drug Discov. Today 2008, 13:268-274.
17. Miro O., Casademont J., Barrientos A., et al. Mitochondrial cytochrome c oxidase inhibition during acute carbon monoxide poisoning. Pharmacol. Toxicol. 1998, 82:199-202.
18. Motterlini R., Clark J.E., Foresti R., et al. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ. Res. 2002, 90:E17-24.
19. Huang L.E., Willmore W.G., Gu J., et al. Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. J. Biol. Chem. 1999, 274:9038-9044.
20. Morita T., Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J. Clin. Invest. 1995, 96:2676-2682.
21. Chin B.Y., Jiang G., Wegiel B., et al. Hypoxia-inducible factor 1α stabilization by carbon monoxide results in cytoprotective preconditioning. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:5109-5114.
22. Choi Y.K., Kim C.K., Lee H., et al. Carbon monoxide promotes VEGF expression by increasing HIF-1α protein level via two distinct mechanisms, translational activation and stabilization of HIF-1α protein. J. Biol. Chem. 2010, 285:32116-32125.
23. Lo Iacono L., Boczkowski J., Zini R., et al. A carbon monoxide-releasing molecule (CORM-3) uncouples mitochondrial respiration and modulates the production of reactive oxygen species. Free Radic. Biol. Med. 2011, 50:1556-1564.
24. Prabhakar N.R., Semenza G.L. Gaseous messengers in oxygen sensing. J. Mol. Med. 2012, 90:265-272.
25. Motterlini R., Otterbein L.E. The therapeutic potential of carbon monoxide. Nat. Rev. Drug Discov. 2010, 9:728-743.
26. Belcher J.D., Chen C., Young M., et al. Prevention of venular stasis, circulatory collapse and mortality in transgenic sickle mice administered MP4CO, a pegylated hemoglobin saturated with carbon monoxide. Blood (ASH Ann. Mtg. Abstracts) 2011, 118. Abstract 850.
27. Sher E.A., Shaklai M., Shaklai N. Carbon monoxide promotes respiratory hemoproteins iron reduction using peroxides as electron donors. PLoS One 2012, 7:e33039.